Hvis betydelig klinisk bedring ikke er set 3 uger efter behandlingens påbegyndelse (uanset dosis), skal Tasmar seponeres.
If substantial clinical benefits are not seen within 3 weeks of the initiation of the treatment (regardless of dose) Tasmar should be discontinued.